11/4
09:23 am
itci
Rating for ITCI
Low
Report
Rating for ITCI
10/31
06:35 am
itci
Rating for ITCI
Low
Report
Rating for ITCI
10/31
06:35 am
itci
Rating for ITCI
Low
Report
Rating for ITCI
10/30
09:25 am
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $100.00 price target on the stock.
High
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $100.00 price target on the stock.
10/30
08:14 am
itci
Rating for ITCI
High
Report
Rating for ITCI
10/30
08:14 am
itci
Rating for ITCI
High
Report
Rating for ITCI
10/11
12:28 pm
itci
Rating for ITCI
Low
Report
Rating for ITCI
10/11
12:28 pm
itci
Rating for ITCI
Low
Report
Rating for ITCI
10/4
10:53 am
itci
Rating for ITCI
Low
Report
Rating for ITCI
10/4
10:53 am
itci
Rating for ITCI
Low
Report
Rating for ITCI
9/20
01:23 pm
itci
Rating for ITCI
Low
Report
Rating for ITCI
9/16
12:11 pm
itci
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $130.00 price target on the stock.
Low
Report
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $130.00 price target on the stock.
9/16
11:49 am
itci
Rating for ITCI
Low
Report
Rating for ITCI